MedPath

HAMAMATSU PHOTONICS K.K.

πŸ‡―πŸ‡΅Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:5

Trial Phases

1 Phases

Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
5 (100.0%)

Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Not Applicable
Completed
Conditions
Pathology
First Posted Date
2019-06-20
Last Posted Date
2022-12-22
Lead Sponsor
Hamamatsu Photonics K.K.
Target Recruit Count
540
Registration Number
NCT03992768
Locations
πŸ‡ΊπŸ‡Έ

Washington University, Saint Louis, Missouri, United States

πŸ‡ΊπŸ‡Έ

The Cleveland Clinic Foundation, Cleveland, Ohio, United States

πŸ‡ΊπŸ‡Έ

The Ohio State University, Columbus, Ohio, United States

Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Not Applicable
Completed
Conditions
Pathology
First Posted Date
2019-06-19
Last Posted Date
2022-12-22
Lead Sponsor
Hamamatsu Photonics K.K.
Target Recruit Count
2000
Registration Number
NCT03991468
Locations
πŸ‡ΊπŸ‡Έ

Washington University, Saint Louis, Missouri, United States

πŸ‡ΊπŸ‡Έ

TriCore Reference Laboratories, Albuquerque, New Mexico, United States

πŸ‡ΊπŸ‡Έ

The Cleveland Clinic Foundation, Cleveland, Ohio, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.